01:00
Unknown
Bayer versus Natco Case: Bayer to Bombay High Court
Natco did not meet preconditions for compulsory license
Bayer challenged IPAB order granting compulsory license to Natco
IPAB granted compulsory license for cancer drug Nexavar
IPAB is Intellectual Property Appellate Board -’Reasonable price’ for sale of Nexavar not specified
Open to few days of free supply in monthly dosages
Spent billions on research for drugs, need to recover through sales
For more information ✆ - 0731-6642300 or Visit http://ift.tt/1doLhaI
Posted in: Indian Market Tips
0 comments:
Post a Comment